Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-038004
Filing Date
2025-03-12
Accepted
2025-03-12 16:36:26
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3889
  Complete submission text file 0000950170-25-038004.txt   5664
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Tripuraneni Radhika (Reporting) CIK: 0001761114 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 25732238